3308 articles
Avery Ince, MD, PhD, Vice President, Medical Affairs, Cardiovascular & Metabolism at the Janssen Pharmaceutical Companies of Johnson & Johnson, discusse...
Marisa Cruz, MD, Chief Medical Officer at Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health...
Fahar Merchant, PhD, President and CEO of Medicenna Therapeutics, a clinical-stage immunotherapy company, discusses the company's Superkine platform and...
Gunderson, PhD, MS, MPH, Senior research scientist at Kaiser Permanente Northern California Division of Research and a professor of Health Systems Sc...
Dr. Ilias Alevizos, DMD, PhD, Executive Medical Director, Clinical Development at Horizon Therapeutics discusses data from the Phase 2 trial results on
Professor Moshe Szyf, Founder and CEO of HKG Epitherapeutics, discusses epigenetic research, the company's novel tools for early detection of cancer and...
Saad Harti, founder and CEO of Swiss-based biotech Legacy Healthcare discusses the company's positive Phase 2/3 data and filing of their lead prescripti...
Jay Backstrom, MD, MPH, President and CEO, and Ted Myles, COO and CFO of Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company, discusses new...
Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie's preliminary data fro...
Minaa B., a licensed mental health professional discusses her new book "Owning Our Struggles" an important book advocating for mental health inclusivity.